BioSpace News Archive

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

Texas orthopaedic surgeon Kevin J. Bozic, MD, MBA, FAAOS, was named first vice president of the American Academy of Orthopaedic Surgeons’ Board of Directors.

Boston orthopaedic trauma surgeon Paul Tornetta III, MD, FAAOS, was named second vice president of the American Academy of Orthopaedic Surgeons’ Board of Directors.

The American Academy of Orthopaedic Surgeons announced New Orleans orthopaedic surgeon Felix H. “Buddy” Savoie III, MD, FAAOS, as its new president for 2022-2023.

New York orthopaedic surgeon Toni M. McLaurin, MD, FAAOS, became a member-at-large of the American Academy of Orthopaedic Surgeons’ Board of Directors.

Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announced today that the Company will host a conference call at 11:00 a.m. ET on Thursday, March 31, 2022 to discuss financial results for the year ended December 31, 2021.

Revelation Biosciences Inc. outlines details on the upcoming data analysis for Phase 2b viral challenge study (RVL-VRL01) to evaluate the efficacy of intranasal REVTx-9.

Abbott (NYSE: ABT) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the expansion of reimbursement coverage for its FreeStyle® Libre system to include all people with diabetes who use insulin at least once a day.

INVO Bioscience, Inc. is exhibiting the INVOcell solution at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting, taking place March 23-27 at the Renaissance Esmeralda Resort & Spa.

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2022 results on Wednesday, May 4, 2022 at 1 p.m. London time (8 a.m. EDT).